Annual Shareholders Equity:
$352.48M+$183.61M(+108.73%)Summary
- As of today (October 5, 2025), DNTH annual stockholders equity is $352.48 million, with the most recent change of +$183.61 million (+108.73%) on December 31, 2024.
- During the last 3 years, DNTH annual shareholders equity has risen by +$179.81 million (+104.13%).
- DNTH annual shareholders equity is now at all-time high.
Performance
DNTH Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Shareholders Equity:
$303.08M-$25.53M(-7.77%)Summary
- As of today (October 5, 2025), DNTH quarterly stockholders equity is $303.08 million, with the most recent change of -$25.53 million (-7.77%) on June 30, 2025.
- Over the past year, DNTH quarterly shareholders equity has dropped by -$55.14 million (-15.39%).
- DNTH quarterly shareholders equity is now -18.68% below its all-time high of $372.69 million, reached on March 31, 2024.
Performance
DNTH Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
DNTH Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +108.7% | -15.4% |
| 3Y3 Years | +104.1% | +123.4% |
| 5Y5 Years | +149.6% | +74.3% |
DNTH Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +378.5% | -18.7% | +311.5% |
| 5Y | 5-Year | at high | +378.5% | -18.7% | +311.5% |
| All-Time | All-Time | at high | +3798.2% | -18.7% | +646.8% |
DNTH Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $303.08M(-7.8%) |
| Mar 2025 | - | $328.61M(-6.8%) |
| Dec 2024 | $352.48M(+108.7%) | $352.48M(+4.3%) |
| Sep 2024 | - | $337.90M(-5.7%) |
| Jun 2024 | - | $358.22M(-3.9%) |
| Mar 2024 | - | $372.69M(+120.7%) |
| Dec 2023 | $168.87M(+129.3%) | $168.87M(-5.3%) |
| Sep 2023 | - | $178.38M(+139.1%) |
| Jun 2023 | - | $74.60M(-3.7%) |
| Mar 2023 | - | $77.46M(+5.2%) |
| Dec 2022 | $73.66M(-57.3%) | $73.66M(-40.6%) |
| Sep 2022 | - | $124.03M(-8.6%) |
| Jun 2022 | - | $135.68M(-10.3%) |
| Mar 2022 | - | $151.19M(-12.4%) |
| Dec 2021 | $172.67M | - |
| Dec 2021 | - | $172.67M(-9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $189.69M(-6.5%) |
| Jun 2021 | - | $202.89M(+57.2%) |
| Mar 2021 | - | $129.06M(-10.3%) |
| Dec 2020 | $143.91M(+1.9%) | $143.91M(-9.2%) |
| Sep 2020 | - | $158.57M(-8.8%) |
| Jun 2020 | - | $173.91M(+38.7%) |
| Mar 2020 | - | $125.40M(-11.2%) |
| Dec 2019 | $141.19M(-3.1%) | $141.19M(-12.6%) |
| Sep 2019 | - | $161.53M(-10.0%) |
| Jun 2019 | - | $179.56M(+34.0%) |
| Mar 2019 | - | $134.00M(-8.0%) |
| Dec 2018 | $145.65M(+189.4%) | $145.65M(-8.8%) |
| Sep 2018 | - | $159.78M(-7.2%) |
| Jun 2018 | - | $172.22M(+324.3%) |
| Mar 2018 | - | $40.59M |
| Dec 2017 | $50.32M(+456.5%) | - |
| Dec 2016 | $9.04M | - |
FAQ
- What is Dianthus Therapeutics, Inc. annual stockholders equity?
- What is the all-time high annual shareholders equity for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. annual shareholders equity year-on-year change?
- What is Dianthus Therapeutics, Inc. quarterly stockholders equity?
- What is the all-time high quarterly shareholders equity for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. quarterly shareholders equity year-on-year change?
What is Dianthus Therapeutics, Inc. annual stockholders equity?
The current annual shareholders equity of DNTH is $352.48M
What is the all-time high annual shareholders equity for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high annual stockholders equity is $352.48M
What is Dianthus Therapeutics, Inc. annual shareholders equity year-on-year change?
Over the past year, DNTH annual stockholders equity has changed by +$183.61M (+108.73%)
What is Dianthus Therapeutics, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of DNTH is $303.08M
What is the all-time high quarterly shareholders equity for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high quarterly stockholders equity is $372.69M
What is Dianthus Therapeutics, Inc. quarterly shareholders equity year-on-year change?
Over the past year, DNTH quarterly stockholders equity has changed by -$55.14M (-15.39%)